Press release
Thyroid Eye Disease Market Report on the Untapped Growth Opportunities in the Industry
According to the latest research by InsightAce Analytic, the Thyroid Eye Disease Market is valued at US$ 2.15 billion in 2023, and it is expected to reach US$ 3.31 billion by 2031, with a CAGR of 5.7% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2893
Thyroid eye disease (TED), also known as Graves' orbitopathy or Graves' ophthalmopathy, is an autoimmune disorder characterized by inflammation and swelling around the eyes. The increasing prevalence of thyroid eye disease is expected to drive market growth in the coming years. Additionally, enhanced healthcare infrastructure, improved patient compliance rates, and advancements in autoimmune disease treatments are key factors contributing to market expansion.
Furthermore, the global thyroid eye disease market is poised to offer significant revenue-generating opportunities for industry participants, driven by rising disposable income levels and ongoing research and development (R&D) initiatives. Substantial investments by leading market players, coupled with technological advancements in treatment solutions, have created lucrative growth prospects for manufacturers and suppliers operating in the thyroid eye disease sector.
List of Prominent Players in the Thyroid Eye Disease Market:
• Horizon Therapeutics
• Viridian Therapeutics
• Pierre Fabre/ACELYRIN
• HanAll Biopharma/Harbour BioMed/Immunovant
• Sling Therapeutics
• Other Market Players
Market Dynamics:
Drivers-
The increasing prevalence of thyroid eye disease (TED) is a primary factor expected to drive market growth. Additionally, enhanced patient compliance, advancements in autoimmune disease treatments, and rising investments in research and development (R&D) are contributing significantly to market expansion. The growing focus on therapeutic innovations and improved treatment accessibility is further anticipated to bolster the global thyroid eye disease market.
Curious About This Latest Version Of The Report? Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/2893
Challenges:
A lack of definitive treatment options and limited awareness in emerging economies are key challenges that may hinder market growth. Additionally, the high cost of treatment is expected to act as a barrier to widespread adoption. The COVID-19 pandemic has further disrupted market dynamics, leading to global supply chain interruptions, economic losses for key industry players, and halted production activities. These disruptions have impacted distributors, suppliers, and retailers, creating challenges for market expansion.
Regional Trends:
North America is projected to dominate the thyroid eye disease market, driven by high disease prevalence, advancements in treatment solutions, and robust R&D investments by key industry players. The region is expected to maintain a strong compound annual growth rate (CAGR) in the coming years. Europe also holds a significant market share, supported by a well-developed healthcare infrastructure and increasing adoption of innovative treatment strategies. The presence of leading market participants and collaborative initiatives aimed at expanding market penetration further strengthens the region's market position.
Recent Developments:
• In March 2024, ACELYRIN, INC. announced positive proof-of-concept results from a Phase 1⁄2 trial of lonigutamab in thyroid eye condition that is now underway. Lonigutamab is a subcutaneous (SC) humanized IgG1 monoclonal antibody that aims the insulin-like growth factor-1 receptor (IGF-1R), a known mechanism of action for thyroid eye disease treatment.
Unlock Your GTM Strategy:
https://www.insightaceanalytic.com/customisation/2893
Segmentation of Thyroid Eye Disease Market-
By Marketed Treatment-
• TEPEZZA (Teprotumumab)
By Pipeline Treatment-
• VRDN 001
• VB 421
• Batoclimab
• Linsitnib
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Get more information:
https://www.insightaceanalytic.com/report/thyroid-eye-disease-market/2893
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Thyroid Eye Disease Market Report on the Untapped Growth Opportunities in the Industry here
News-ID: 3939597 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Mining Equipment Market Future Trends and Scope Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Mining Equipment Market Size, Share & Trends Analysis Report By Equipment Type (Underground Mining Equipment, Surface Mining Equipment, Crushing, Pulverizing & Screening Equipment, Drills & Breakers), By Application (Metal Mining, Non-Metal Mining, Coal Mining)- Market Outlook And Industry Analysis 2031"
The Global Mining Equipment Market is estimated to reach over USD 34.07 billion by 2031, exhibiting…
Minimal Residual Disease Market Report on the Untapped Growth Opportunities in t …
InsightAce Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Minimal Residual Disease Market (By Indication ( Leukemia, Acute Lymphoblastic Leukemia (All), Chronic Lymphoblastic Leukemia (CLL), Acute Myeloid Leukemia (AML, Chronic Myeloid Leukemia (CML), Others, Lymphoma, Non-Hodgkin's Lymphoma (NHL), Marginal Zone Lymphoma, Follicular Lymphoma, Peripheral T-Cell Lymphoma, Mantle Cell Lymphoma, Others, Multiple Myeloma (MM), Solid Tumor, And Others), Detection (Next-Generation Sequencing (NGS), Flow Cytometry, Polymerase…
Microdermabrasion Devices Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Microdermabrasion Devices Market Size, Share & Trends Analysis Report By Type (Diamond, Crystal Microdermabrasion Devices), Application (Acne And Scars, Photo Damage, Anti-Aging, Hyperpigmentation, Stretch Marks) And End User (Hospitals And Clinics And Home Use)- Market Outlook And Industry Analysis 2031"
The Global Microdermabrasion Devices Market is estimated to reach over USD 1149.25 million by 2031, exhibiting…
Micro Injection Molded Plastic Market Revenue Report with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Micro Injection Molded Plastic Market Size, Share & Trends Analysis Report By Material type (Liquid-Crystal Polymer (LCP), Polyether Ether (PEEK), Polycarbonate (PC), Polyethylene (PE), Polyoxymethylene (POM), Polymethyl Methacryate (PMMA), Polyetherimide (PEI), Polybutylene Terephthalate (PBT), Others) By Application (Medical, Automotive, Optics, Electronics), Region, Market Outlook And Industry Analysis 2031"
The Global Micro Injection Molded Plastic Market is…
More Releases for Thyroid
Thyroid Cancer Treatment Market Increasing Ageing Population and Thyroid Cancer …
The thyroid cancer treatment market is projected to grow with a moderate CAGR during the forecast period, i.e., 2021-2029 on account of the increasing healthcare expenditure and the rising prevalence of thyroid cancer. As per The American Society of Clinical Oncology, in 2020, 44,280 number of adults in the United States is estimated to suffer from thyroid cancer. Such increasing prevalence of thyroid cancer is further expected to drive the…
Thyroid Gland Disorders Treatment Market Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of…
Thyroid Gland Disorder Treatment Market: Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of…
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
Thyroid gland is made of thyroid cells that absorb iodine from food and convert it into triiodothyronine (T3) and thyroxine (T4). These hormones are released into the blood stream and play an important role in the regulation of metabolism. Thyroid gland disorders are defined as an abnormal release of thyroid hormones which may demand proper therapeutic agents to correct the disorder condition. This report studies the market in a view…
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
Thyroid gland is made of thyroid cells that absorb iodine from food and convert it into triiodothyronine (T3) and thyroxine (T4). These hormones are released into the blood stream and play an important role in the regulation of metabolism. Thyroid gland disorders are defined as an abnormal release of thyroid hormones which may demand proper therapeutic agents to correct the disorder condition. This report studies the market in a view…
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
The number of patients suffering from thyroid gland disorders across the globe is increasing at a rapid rate. This direct increase in demand is expected to be a primary driver for the development of thyroid gland disorder treatments. The number of patients with thyroid gland disorder is increasing due to a growing population of the elderly, who are prone to thyroid disorders and similar illnesses.
Additionally, a person suffering from…
